| Aug 6 |
Applied Therapeutics, Inc. (NASDAQ:APLT): When Will It Breakeven?
|
| Jul 31 |
Rare Disease-Focused Applied Therapeutics' Lead Candidate Govorestat Has Blockbuster Potential, Analyst Sees 140% Stock Upside
|
| Jul 1 |
Applied Therapeutics joins Russell 3000 Index
|
| Jul 1 |
Applied Therapeutics Added to Russell 3000® Index
|
| Jun 30 |
Why Is Applied Therapeutics, Inc. (APLT) the Best Biotech Penny Stock to Buy Now?
|
| Jun 26 |
Here's Why We're Not Too Worried About Applied Therapeutics' (NASDAQ:APLT) Cash Burn Situation
|
| Jun 11 |
Top 4 Health Care Stocks That May Keep You Up At Night This Month
|
| May 29 |
Applied Therapeutics: A Strong Buy With AT-007 Nearing Approval For Galactosemia
|
| May 28 |
Applied Therapeutics: Navigating Challenges In ARI Development For Rare Diseases
|
